O
Outset Medical, Inc. (OM)
NMS – Real Time Price. Currency in USD
3.84
+0.19 (5.21%)
At close: May 12, 2026, 4:00 PM EDT
Find any stock by ticker or company name

NMS – Real Time Price. Currency in USD
3.84
+0.19 (5.21%)
At close: May 12, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 6.29 | 3.40 | 10 | |
| Quick ratio | 4.97 | 2.52 | 10 | |
| Debt to Equity | 0.91 | 1.11 | 6.0 | |
| Debt to Assets | 0.41 | 1.58 | 6.0 | |
| Interest coverage | -5.02 | 4.33 | 1.0 | |
| Weighted average score | 6.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 115M | 130M | 114M | 119M | 118M |
| Gross Profit | 18M | 29M | 39M | 47M | 48M |
| Operating Income | -161M | -170M | -108M | -67M | -67M |
| Net Income | -163M | -173M | -128M | -82M | -75M |
| EBITDA | -155M | -164M | -102M | -62M | -63M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -4.99 | 14.68 | 4.5 |
| Next quarter | 15.65 | 10.63 | 8.0 |
| Current year | 5.94 | 32.71 | 7.5 |
| Next year | 10.87 | 24.65 | 8.5 |
| Weighted average score | 7.1 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -3.49 | 2.63 | 1.19 | -32.47 | 2.3 |
| Y/Y | -6.34 | 26.39 | 74.38 | 49.94 | 7.8 |
| 3y average | 1.77 | 18.7 | 40.65 | 28.45 | 8.0 |
| 5y average | 24.64 | 4.8 | 27.74 | 9.3 | 7.5 |
| Weighted average score | 6.4 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Total debt $101.6M significantly exceeds cash reserves ($30.6M), raising financial stability concerns
Total current assets $236.7M exceed Total current liabilities $37.6M, highlighting excellent liquidity
Debt-to-equity ratio (0.9) is near the industry average, reflecting balanced leverage
Interest coverage ratio (-5.0x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$12.9M limits the company's ability to reinvest or pay down debt